About Duane Mitchell
Duane Anthony Mitchell, MD, PhD, is co-director of the Preston A. Wells Jr. Center for Brain Tumor Therapy and director of the UF Brain Tumor Immunotherapy Program. He is the Phyllis Kottler Friedman Professor for the Department of Neurosurgery and the State of Florida Endowed Cancer Research Chair at the UF College of Medicine.
Dr. Mitchell graduated from Rutgers College in New Brunswick, with a bachelor’s degree in biology before receiving his medical degree and doctorate degree in immunology from Duke University in Durham, in 2001. Dr. Mitchell conducted his postgraduate training in pathology and a neuro-oncology research at Duke University Medical Center prior to joining the faculty as an assistant professor.
During his tenure at Duke, Dr. Mitchell held positions such as preclinical research at the Preston Robert Tisch Brain Tumor Center and associate director of the Duke Brain Tumor Immunotherapy Program. He also served as an active member of several institutional regulatory boards governing the conduct of human clinical trials.
In 2013, Dr. Mitchell joined the University of Florida faculty where he leads a comprehensive brain tumor program focused on translational research. This addition to the brain tumor program at UF was made possible by the Wells Foundation gift, combined with matching funds from other university sources, totaling $20 million dedicated to brain tumor treatment and research.
He has considerable clinical and translational research experience, having served as principal investigator on nine first-in-human protocols through FDA-approved clinical trials. The goal of these trials is to see improvements in patient outcomes using novel approaches that stimulate immune responses against malignant brain tumor cells in combination with current standard treatments. Dr. Mitchell’s research team will expand upon early successes observed in these personalized cancer treatment approaches and offer unique clinical options at UF Health for adult and pediatric patients diagnosed with malignant brain tumors.
Dr. Mitchell currently serves as a chartered member of the National Institutes of Health Study Section on Cancer Immunopathology and Immunotherapy, chair of the NCI Pediatric Brain Tumor Consortium Immunotherapy Committee, member of the NCI Brain Malignancy Steering Committee Immunotherapy Working Group, and gubernatorial appointee to the Florida Center for Brain Tumor Research Scientific Advisory Council. He has more than 50 refereed journal publications and 17 textbook chapters and scientific reviews and is inventor on eight filed United States patents on findings from his oncological research. Dr. Mitchell has been invited to serve on several scientific advisory